0000899243-23-009095.txt : 20230320
0000899243-23-009095.hdr.sgml : 20230320
20230320160517
ACCESSION NUMBER: 0000899243-23-009095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230316
FILED AS OF DATE: 20230320
DATE AS OF CHANGE: 20230320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bachleda Mark
CENTRAL INDEX KEY: 0001887762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 23746416
MAIL ADDRESS:
STREET 1: C/O GALERA THERAPEUTICS, INC.
STREET 2: 2 W LIBERTY BOULEVARD, #110
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 134
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: P.O. BOX 134
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-16
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001887762
Bachleda Mark
C/O GALERA THERAPEUTICS, INC.
P.O. BOX 134
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
0
Common Stock
2023-03-16
4
P
0
11000
2.247
A
11000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Chris Degnan, Attorney-in-Fact for Mark Bachleda
2023-03-20